Sirolimus, originally known as rapamycin, is a highly potent, broad-acting compound, the ability of the disease through several mechanisms of action, including immunosuppressive agents, showed anti-angiogenic, anti – migratory, anti combat has proliferative-, and anti – permeability antifibrotic activity us pharmacy online prescription . Based on the versatility associated with these multiple mechanisms of action, MacuSight believes that its sirolimus can serve as a potentially highly effective treatment for a variety of eye diseases and conditions, including the treatment and prevention of wet AMD.
The results of the study appear in the September issue of Cancer Cell. Jing Chen, assistant professor of hematology and oncology at Emory Winship and Georgia Cancer Coalition Distinguished Cancer Scholar is senior author on the paper. Sumin Kang, a postdoctoral fellow at Emory Winship, is the paper’s first author.
University of Iowa in research have created a new imaging modality for the identification a rare type of thyroid cancer, which is typically develop to diagnose. An accurate diagnosis the cancer, like poorly differentiated Thyroid is known, is help physicians choose to the best treatment for the patient.The results of this study, that 18th in the September issue of the in New England Journal of Medicine seem throw the opportunity to the extending the use of radioactive iodine treatment of thyroid cancer diseases, for which the gland can not be can not may not be not be could not be surgically removed.